Viridian Therapeutics Inc

XNAS: VRDN

Download real time

12.02 0.61 (5.35%)

New 52W Low in past week

1.2M XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

979.4

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 17 analysts

Viridian Therapeutics Inc has a share price target of US$ 40, revenue growth forecast of -46.7%, and profit growth estimate of -24.4% for FY25, based on top 17 analyst calls.

Forecaster Screeners